🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will examine the safety and effectiveness of a bone marrow trans...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Start Date
2023-10-01
Trial ID
NCT05900401
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Status
Completed
Location
AZ Sint-Jan
Start Date
2003-11
Trial ID
NCT00077116
RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamid...
Status
Active Not Recruiting
Location
Regional Medical Center
Start Date
2003-11
Trial ID
NCT00070564
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
Retinoblastoma is a childhood cancer which affects the retina of the eye. T...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2005-04-07
Trial ID
NCT00186888
Chronic inflammatory demyelinating polyneuropathy is disease believed to be...
Status
Completed
Location
Northwestern University, Feinberg School of Medicine
Start Date
2005-02-21
Trial ID
NCT00278629
Treatments Being Tested
Our study is a prospective, non-inferior, randomized phase II clinical tria...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT02838225
Treatments Being Tested
This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Status
Completed
Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Start Date
2022-07-05
Trial ID
NCT05415215
Sinonasal tumors are rare diseases, as they account for the 0.2 % - 0.8 % o...
Status
Unknown
Location
Presidio Ospedaliero Spedali Civili di Brescia
Start Date
2013-11
Trial ID
NCT02099188
This phase II trial studies if itacitinib plus standard of care treatment m...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2022-01-11
Trial ID
NCT04859946